How do you treat an isolated in-transit recurrence of melanoma without evidence of clinical nodal involvement in a patient with a history of previously resected primary melanoma?
Would you recommend neoadjuvant immunotherapy as per NADINA or S1801?
Answer from: Medical Oncologist at Academic Institution
If the patient does not have a clinical lymph node, then neither of those two trials is applicable. We treat "isolated" in-transit metastasis with T-VEC first. Surgical resection can be done later if there is less than a complete pathologic response.